Selective norepinephrine reuptake inhibitor and purpose thereof in preparation of medicament for attention deficit / hyperactivity disorder

A kind of use, the technology of medicinal salt, applied in the field of preparation of attention deficit hyperactivity disorder drugs, can solve the problems of limited treatment application, patient intolerance, addiction and abuse, etc., to reduce the dosage, enhance the reversal effect, and have small side effects Effect
CN102250053AInactive Publication Date: 2011-11-23苏州波锐生物医药科技有限公司
0 Cites 1 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
苏州波锐生物医药科技有限公司
Publication Date
2011-11-23
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a compound, which can be used as a selective norepinephrine reuptake inhibitor, and a purpose thereof in preparation of medicaments for ADHD (attention deficit / hyperactivity disorder). Compared with a central nervous system stimulant methylphenidate, the compound of the invention will not induce twitch or worsen dyskinesia, has little side effect, and is more suitable for ADHD patients. In addition, ADHD medicaments prepared from the compound of the invention have small application dosage.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to a selective norepinephrine reuptake inhibitor and its use in preparing a drug for attention deficit hyperactivity disorder. Background technique

[0002] Attention deficit / hyperactivity disorder (ADHD) mostly begins around age 3 years, often persists into adolescence and 60% persist into adults. Its main clinical features are distraction, hyperactivity and impulsive behavior, which can be manifested as difficulty in completing tasks, forgetting, low frustration tolerance, risky behavior, and often comorbid with a variety of mental disorders such as anxiety disorders, depressive disorders, and bipolar disorder. , antisocial personality disorder, substance abuse and dependence, etc., resulting in impaired life, work, and social functions of patients and huge medical and socioeconomic burdens.

[0003] Drug therapy is the main treatment method for ADHD, and central stimulants (such as methylphenidate, dextroamphetamine) a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More